These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 16779661

  • 21. Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.
    Harikumar KG, Hosohata K, Pinon DI, Miller LJ.
    J Biol Chem; 2006 Feb 03; 281(5):2543-50. PubMed ID: 16319066
    [Abstract] [Full Text] [Related]

  • 22. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R, Brennauer A, Schneider E, Cabrele C, Beck-Sickinger AG, Bernhardt G, Buschauer A.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):10-8. PubMed ID: 17027743
    [Abstract] [Full Text] [Related]

  • 23. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
    Chen H, Chung NN, Lemieux C, Zelent B, Vanderkooi JM, Gryczynski I, Wilkes BC, Schiller PW.
    Biopolymers; 2005 Dec 03; 80(2-3):325-31. PubMed ID: 15614807
    [Abstract] [Full Text] [Related]

  • 24. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
    Holleran BJ, Beaulieu ME, Proulx CD, Lavigne P, Escher E, Leduc R.
    Biochem J; 2007 Feb 15; 402(1):51-61. PubMed ID: 17064254
    [Abstract] [Full Text] [Related]

  • 25. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT, Gera L, Morissette G, Bouthillier J, Stewart JM, Gobeil LA, Lodge R, Adam A, Marceau F.
    J Pharmacol Exp Ther; 2009 Apr 15; 329(1):159-68. PubMed ID: 19136639
    [Abstract] [Full Text] [Related]

  • 26. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
    Foucaud M, Archer-Lahlou E, Marco E, Tikhonova IG, Maigret B, Escrieut C, Langer I, Fourmy D.
    Regul Pept; 2008 Jan 10; 145(1-3):17-23. PubMed ID: 17961734
    [Abstract] [Full Text] [Related]

  • 27. Purification and fluorescent labeling of the human serotonin transporter.
    Rasmussen SG, Gether U.
    Biochemistry; 2005 Mar 08; 44(9):3494-505. PubMed ID: 15736959
    [Abstract] [Full Text] [Related]

  • 28. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist.
    Roettger BF, Pinon DI, Burghardt TP, Miller LJ.
    Am J Physiol; 1999 Mar 08; 276(3):C539-47. PubMed ID: 10069980
    [Abstract] [Full Text] [Related]

  • 29. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP, Tiberi M.
    Cell Signal; 2010 Jan 08; 22(1):106-16. PubMed ID: 19786093
    [Abstract] [Full Text] [Related]

  • 30. Cholesterol as modulator of receptor function.
    Gimpl G, Burger K, Fahrenholz F.
    Biochemistry; 1997 Sep 09; 36(36):10959-74. PubMed ID: 9283088
    [Abstract] [Full Text] [Related]

  • 31. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
    Gupta S, Singh RK, Nanda K, Chatterjee M, Tiwari A, Sundaram S, Gupta D, Chugh A, Dastidar S, Ray A.
    J Recept Signal Transduct Res; 2009 Sep 09; 29(2):100-6. PubMed ID: 19288301
    [Abstract] [Full Text] [Related]

  • 32. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes.
    Zürn A, Zabel U, Vilardaga JP, Schindelin H, Lohse MJ, Hoffmann C.
    Mol Pharmacol; 2009 Mar 09; 75(3):534-41. PubMed ID: 19106230
    [Abstract] [Full Text] [Related]

  • 33. Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.
    Albizu L, Teppaz G, Seyer R, Bazin H, Ansanay H, Manning M, Mouillac B, Durroux T.
    J Med Chem; 2007 Oct 04; 50(20):4976-85. PubMed ID: 17850055
    [Abstract] [Full Text] [Related]

  • 34. Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization.
    Hollenberg MD, Renaux B, Hyun E, Houle S, Vergnolle N, Saifeddine M, Ramachandran R.
    J Pharmacol Exp Ther; 2008 Aug 04; 326(2):453-62. PubMed ID: 18477767
    [Abstract] [Full Text] [Related]

  • 35. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 36. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032
    [Abstract] [Full Text] [Related]

  • 37. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
    Middleton RJ, Briddon SJ, Cordeaux Y, Yates AS, Dale CL, George MW, Baker JG, Hill SJ, Kellam B.
    J Med Chem; 2007 Feb 22; 50(4):782-93. PubMed ID: 17249651
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure.
    Lacivita E, Leopoldo M, Masotti AC, Inglese C, Berardi F, Perrone R, Ganguly S, Jafurulla M, Chattopadhyay A.
    J Med Chem; 2009 Dec 10; 52(23):7892-6. PubMed ID: 19705871
    [Abstract] [Full Text] [Related]

  • 39. Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor.
    Harikumar KG, Cawston EE, Miller LJ.
    Assay Drug Dev Technol; 2011 Aug 10; 9(4):394-402. PubMed ID: 21395402
    [Abstract] [Full Text] [Related]

  • 40. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
    Schneider E, Mayer M, Ziemek R, Li L, Hutzler C, Bernhardt G, Buschauer A.
    Chembiochem; 2006 Sep 10; 7(9):1400-9. PubMed ID: 16888730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.